Establishing a CRISPR/Cas9 genome editing framework in pigeonpea (Cajanus cajan L.) by targeting phytoene desaturase (PDS) gene disruption
K Senthil,
Maniraj Rathinam,
Manisha Parashar
и другие.
Journal of Genetic Engineering and Biotechnology,
Год журнала:
2025,
Номер
23(1), С. 100465 - 100465
Опубликована: Фев. 6, 2025
Язык: Английский
Classification of Vase Life Day Based on Petal Colorimetric Data in Cut Lisianthus Using AutoML
Horticulturae,
Год журнала:
2024,
Номер
10(10), С. 1033 - 1033
Опубликована: Сен. 29, 2024
This
study
investigated
the
potential
of
petal
colorimetric
data
to
classify
vase
life
stages
in
cut
lisianthus
flowers
(Eustoma
grandiflorum).
We
analyzed
changes
color
space
over
time,
focusing
on
b*
value
as
an
indicator
senescence
due
increasing
yellowing
caused
by
copigmentation.
A
comparative
analysis
was
conducted
between
two
cultivation
methods:
soil
(S)
and
hydroponic
(H)
cultivation.
The
objective
evaluate
performance
machine
learning
models
trained
based
data.
Automated
exhibited
better
H-cultivated
flowers,
effectively
distinguishing
days
within
from
Days
1
14
for
H
Cut
cultivated
under
S
conditions
showed
less
variation
9,
maintaining
a
relatively
uniform
range.
made
it
more
difficult
distinguish
compared
These
findings
demonstrate
that
metrics
can
serve
reliable
indicators
flower
potentially
facilitate
nondestructive
methods
classifying
stages.
technology
holds
promise
wider
applications
floriculture
industry,
improving
quality
control,
extending
various
cut-flower
crops.
Язык: Английский
Targeted Gene Therapy: Promises and Challenges in Disease Management
A.S. Vickram,
Sivasubaramanian Manikandan,
Titus Richard
и другие.
Journal of Bio-X Research,
Год журнала:
2024,
Номер
7
Опубликована: Янв. 1, 2024
Targeted
gene
therapy
may
revolutionize
disease
treatment
by
precisely
treating
genetic
defects.
This
method
targets
particular
cells
or
tissues
with
therapeutic
genes
to
treat
a
variety
of
problems,
including
cancer,
hereditary
diseases,
and
viral
infections.
Viral,
nonviral,
genome
editing
techniques
such
as
CRISPR-Cas9
are
used
for
targeted
fix
modify
disease-causing
minimal
off-target
effects.
The
issues
vector
immunogenicity,
mutations,
delivery
target
persist
despite
tremendous
progress.
successful
implementation
is
further
hindered
illness
complexity
background
diversity.
These
difficulties
require
multidisciplinary
cooperation,
novel
design,
thorough
preclinical
clinical
assessments.
long-term
unforeseen
effects
must
also
be
considered
from
an
ethical
viewpoint.
has
considerable
promise,
but
more
research
technological
advances
needed
overcome
limitations
develop
safe
treatments.
Язык: Английский